In the early stages of CKD, production of 1,25-(OH)2D3 may be impaired by elevated serum phosphorus and loss of 1-alpha-hydroxylase activity, in conjunction with inhibition of production and increased degradation of 1,25-(OH)2D3 by FGF-23 (15). This evidence concerns the gene FGF23 and chronic kidney disease.